DEGs manifested several interesting functions, with respect to the experimental setup, where they appeared to participate in response to drug functions, the relaxin signaling pathway, colorectal cancer, the NF-κB survival pathway and IL3 signaling pathway (Figure 10). This evidence concerns the gene NFKB1 and colorectal cancer.